Sosei Heptares Webinar Presentation for FY2023 Financial Results Novartis Automates New Radioligand Therapy

continues with the basics learned in Course 1 and extends the ideas to apply GPCR utilization in drug therapy

Proof-of-Concept Data From Phase 2a Clinical Study Neurocrine opening two Phase 1 trials in oral Parkinson’s therapies

against Candida auris FKBP12 Development and therapeutic perspectives of CXCR4 antagonists for disease therapy

diseases, and understanding the mechanisms of these complex molecules is crucial for developing effective therapies

adenylyl cyclases in cancer Olfactory Receptors and Tumorigenesis: Implications for Diagnosis and Targeted Therapy

Consistently, GPR84-/- mice are resistant to the development of colitis induced by DSS.

adenosine signaling and ABC transporters, which extrude drugs outside the cell, such as the multidrug resistance-associated

The chimeric antigen receptor T cell therapy could also be a way to target tumor cells expressing ectopic

Register today as a @DrGPCR site member to attend for Free! ➡️https://bit.ly/3Q7hlnT #gpcr #drgpcr

Did you register for our next Dr. GPCR Virtual Cafe? Register today! Addgene's Dr.

Register here (FREE) https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe #drgpcr #gpcr #virtualcafe

Register here (FREE) https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

Register here (free): https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #podcast

Register today: https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

Register here

benzyl isothiocyanate: A promising phytochemical-based drug discovery approach for combating multi-drug resistant

fibroblasts] Methods & Updates in GPCR Research Highly efficient GPCR immobilization with enhanced fouling resistance

peptidergic systems GPCR Binders, Drugs, and more A relaxin receptor gene RpGPCR41 is involved in the resistance

CCR2 was also shown to be resistant to degradation and most likely recycling through the trans-Golgi Aiello et. al 2010) which may ultimately compete with receptor antagonists, thereby decreasing the efficacy

Register now and level up your expertise!

Register by September 6, 12 pm EST. September 22: Don't miss the Dr.

Stay tuned for more details, and be ready to register in July 2024. Dr.

If you have registered, please submit poster abstracts through this form and the short talk selections

If you are on the waitlist, you'll be the first notified and can register for the course ahead of everyone

You have until 5 pm EST tomorrow to register.

You have until May 3rd, 2023 to register.

If you missed the chance to register, don't worry!